Literature DB >> 24550287

Cartilage-specific deletion of Mig-6 results in osteoarthritis-like disorder with excessive articular chondrocyte proliferation.

Ben Staal1, Bart O Williams, Frank Beier, George F Vande Woude, Yu-Wen Zhang.   

Abstract

A deficiency of mitogen-inducible gene-6 (Mig-6) in mice leads to the development of an early-onset, osteoarthritis (OA)-like disorder in multiple synovial joints, underlying its importance in maintaining joint homeostasis. Here we determined what joint tissues Mig-6 is expressed in and what role chondrocytes play in the Mig-6-deficient OA-like disorder. A Mig-6/lacZ reporter mouse strain expressing β-galactosidase under the control of the Mig-6 gene promoter was generated to determine Mig-6 expression in joint tissues. By β-galactosidase staining, we demonstrated that Mig-6 was uniquely expressed in the cells across the entire surface of the synovial joint cavity, including chondrocytes in the superficial zone of articular cartilage and in the meniscus, as well as synovial lining cells. By crossing Mig-6-floxed mice to Col2a1-Cre transgenic mice, to generate cartilage-specific deletion of Mig-6, we demonstrated that deficiency of Mig-6 in the chondrocytes results in a joint phenotype that only partially recapitulates the OA-like disorder of the Mig-6-deficient mice: Ubiquitous deletion of Mig-6 led to the OA-like disorder in multiple joints, whereas cartilage-specific deletion affected the knees but rarely other joints. Furthermore, chondrocytes with Mig-6 deficiency showed excessive proliferative activities along with enhanced EGF receptor signaling in the articular cartilage and in the abnormally formed osteophytes. Our findings provide insight into the crucial requirement for Mig-6 in maintaining joint homeostasis and in regulating chondrocyte activities in the synovial joints. Our data also suggest that other cell types are required for fully developing the Mig-6-deficient OA-like disorder.

Entities:  

Keywords:  EGFR; Errfi1; Gene 33; RALT

Mesh:

Substances:

Year:  2014        PMID: 24550287      PMCID: PMC3932925          DOI: 10.1073/pnas.1400744111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  The role of the chondrocyte in osteoarthritis.

Authors:  M B Goldring
Journal:  Arthritis Rheum       Date:  2000-09

2.  The critical role of the epidermal growth factor receptor in endochondral ossification.

Authors:  Xianrong Zhang; Valerie A Siclari; Shenghui Lan; Ji Zhu; Eiki Koyama; Holly L Dupuis; Motomi Enomoto-Iwamoto; Frank Beier; Ling Qin
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

3.  Mig-6 is a negative regulator of the epidermal growth factor receptor signal.

Authors:  P O Hackel; M Gishizky; A Ullrich
Journal:  Biol Chem       Date:  2001-12       Impact factor: 3.915

4.  Targeted disruption of Mig-6 in the mouse genome leads to early onset degenerative joint disease.

Authors:  Yu-Wen Zhang; Yanli Su; Nathan Lanning; Pamela J Swiatek; Roderick T Bronson; Robert Sigler; Richard W Martin; George F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-08       Impact factor: 11.205

Review 5.  Articular cartilage and osteoarthritis.

Authors:  Joseph A Buckwalter; Henry J Mankin; Alan J Grodzinsky
Journal:  Instr Course Lect       Date:  2005

6.  EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix.

Authors:  Ji Zhu; Emi Shimizu; Xianrong Zhang; Nicola C Partridge; Ling Qin
Journal:  J Cell Biochem       Date:  2011-07       Impact factor: 4.429

7.  A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation.

Authors:  Yuri Frosi; Sergio Anastasi; Costanza Ballarò; Giulia Varsano; Loriana Castellani; Elena Maspero; Simona Polo; Stefano Alemà; Oreste Segatto
Journal:  J Cell Biol       Date:  2010-04-26       Impact factor: 10.539

8.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.

Authors:  Reva C Lawrence; David T Felson; Charles G Helmick; Lesley M Arnold; Hyon Choi; Richard A Deyo; Sherine Gabriel; Rosemarie Hirsch; Marc C Hochberg; Gene G Hunder; Joanne M Jordan; Jeffrey N Katz; Hilal Maradit Kremers; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2008-01

9.  Transforming growth factor alpha suppression of articular chondrocyte phenotype and Sox9 expression in a rat model of osteoarthritis.

Authors:  C Thomas G Appleton; Shirine E Usmani; Suzanne M Bernier; Thomas Aigner; Frank Beier
Journal:  Arthritis Rheum       Date:  2007-11

10.  Rho/ROCK and MEK/ERK activation by transforming growth factor-alpha induces articular cartilage degradation.

Authors:  C Thomas G Appleton; Shirine E Usmani; John S Mort; Frank Beier
Journal:  Lab Invest       Date:  2009-10-12       Impact factor: 5.662

View more
  25 in total

1.  Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is increased in osteoarthritis and regulates chondrocyte catabolic and anabolic activities.

Authors:  D L Long; V Ulici; S Chubinskaya; R F Loeser
Journal:  Osteoarthritis Cartilage       Date:  2015-04-29       Impact factor: 6.576

Review 2.  Building and maintaining joints by exquisite local control of cell fate.

Authors:  Joanna Smeeton; Amjad Askary; J Gage Crump
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2016-09-01       Impact factor: 5.814

3.  Serum Metabolite Profiles Are Altered by Erlotinib Treatment and the Integrin α1-Null Genotype but Not by Post-Traumatic Osteoarthritis.

Authors:  Beata Mickiewicz; Sung Y Shin; Ambra Pozzi; Hans J Vogel; Andrea L Clark
Journal:  J Proteome Res       Date:  2016-01-28       Impact factor: 4.466

Review 4.  Novel Insights into Osteoarthritis Joint Pathology from Studies in Mice.

Authors:  Paxton M Moon; Frank Beier
Journal:  Curr Rheumatol Rep       Date:  2015-08       Impact factor: 4.592

Review 5.  Mouse genetic models for temporomandibular joint development and disorders.

Authors:  A Suzuki; J Iwata
Journal:  Oral Dis       Date:  2015-07-02       Impact factor: 3.511

6.  EGFR signaling is critical for maintaining the superficial layer of articular cartilage and preventing osteoarthritis initiation.

Authors:  Haoruo Jia; Xiaoyuan Ma; Wei Tong; Basak Doyran; Zeyang Sun; Luqiang Wang; Xianrong Zhang; Yilu Zhou; Farid Badar; Abhishek Chandra; X Lucas Lu; Yang Xia; Lin Han; Motomi Enomoto-Iwamoto; Ling Qin
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-28       Impact factor: 11.205

7.  Disturbed cartilage and joint homeostasis resulting from a loss of mitogen-inducible gene 6 in a mouse model of joint dysfunction.

Authors:  Michael A Pest; Bailey A Russell; Yu-Wen Zhang; Jae-Wook Jeong; Frank Beier
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995

8.  Mitogen-inducible gene-6 partly mediates the inhibitory effects of prenatal dexamethasone exposure on endochondral ossification in long bones of fetal rats.

Authors:  Xianrong Zhang; Yangfan Shang-Guan; Jing Ma; Hang Hu; Linlong Wang; Jacques Magdalou; Liaobin Chen; Hui Wang
Journal:  Br J Pharmacol       Date:  2016-06-02       Impact factor: 8.739

9.  Lin28a overexpression reveals the role of Erk signaling in articular cartilage development.

Authors:  Tatsuya Kobayashi; Anastasia Kozlova
Journal:  Development       Date:  2018-08-02       Impact factor: 6.868

10.  FoxO transcription factors modulate autophagy and proteoglycan 4 in cartilage homeostasis and osteoarthritis.

Authors:  Tokio Matsuzaki; Oscar Alvarez-Garcia; Sho Mokuda; Keita Nagira; Merissa Olmer; Ramya Gamini; Kohei Miyata; Yukio Akasaki; Andrew I Su; Hiroshi Asahara; Martin K Lotz
Journal:  Sci Transl Med       Date:  2018-02-14       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.